Ipsen CEO Says Doctor Response To Crackdown Affecting China Sales
This article was originally published in PharmAsia News
Executive Summary
The CEO of French drug-maker Ipsen says China physicians are changing their habits as a result of the major corruption investigations in the pharmaceutical business, making it harder to conduct business there.